TABLE 5.

Correlations between the percent change in HDL-C and the percent changes in candidate HDL-C determinants in response to rosiglitazone treatment (n = 14)

	Correlation Coefficient,Unadjusted	Correlation Coefficient,Adjusted for BMI and Smoking
ApoA-I concentration	0.35	0.44
ApoA-I FCR	−0.26	−0.14
ApoA-I PR	0.00	0.18
ApoA-II concentration	0.80b	0.83b
ApoA-II FCR	−0.53a	−0.51
ApoA-II PR	−0.07	−0.05
Fasting insulin	0.21	0.42
Fasting glucose	−0.25	−0.23
HOMA	0.08	0.27
HsCRP	−0.11	−0.14
Triglyceride	−0.45	−0.50
ApoC-III	−0.60a	−0.50
Nonesterified FAs	−0.66a	−0.68a

^aP ≤ 0.05.

^bP ≤ 0.001.